U.S. Tech Hardware Stock News

XOMA Royalty (XOMA) FY 2025 earnings snapshot XOMA Royalty (XOMA) has wrapped up FY 2025 with fourth quarter revenue of US$13.8 million and basic EPS of US$0.50, alongside net income of US$6.1 million. On a trailing twelve month view, revenue sits at US$52.1 million and EPS at US$2.62. Over the past six reported quarters, the company has seen quarterly revenue range from US$7.2 million to US$15.9 million, with basic EPS moving from a loss of US$1.59 per share in late 2024 to positive...

Lineage, Inc. recently announced that its Board of Directors approved a first-quarter 2026 cash dividend of US$0.5325 per share, an annualized US$2.13 per share, representing a 1% increase from the fourth quarter of 2025 and payable on April 21, 2026 to shareholders of record on March 31, 2026. This incremental dividend increase highlights management’s willingness to return more cash to shareholders, which can matter for investors focused on recurring income streams. Next, we’ll examine how...

Recent performance snapshot for TransDigm Group TransDigm Group (TDG) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year to date. Over the past year, the total return also sits in negative territory, while the 3 year and 5 year total returns remain positive. That combination of recent weakness and longer term gains is shaping how investors are reassessing the current share...

MasTec stock jumps on record backlog and long term guidance MasTec (MTZ) is back in focus after management outlined guidance for US$17b in revenue and adjusted EPS of US$8.40 in 2026, supported by a record US$18.96b backlog. The stock has returned about 140% over the past year. The combination of multi segment growth and sizeable contracted work is shaping how investors are reassessing MasTec’s infrastructure exposure and earnings profile. See our latest analysis for MasTec. Despite a recent...

Cogent Biosciences recently announced that the FDA has accepted its New Drug Application for bezuclastinib in Non-Advanced Systemic Mastocytosis, assigning a December 30, 2026 PDUFA action date and indicating no current plans for an advisory committee or identified review issues. What stands out is that bezuclastinib’s pivotal SUMMIT trial not only met all primary and key secondary endpoints but also showed symptomatic improvement deepening over 48 weeks, suggesting potential for sustained...

Lattice Semiconductor (LSCC) has attracted fresh attention after joining NVIDIA’s Halos AI Systems Inspection Lab ecosystem, a move that links its low power FPGA portfolio directly to safety focused physical AI projects. See our latest analysis for Lattice Semiconductor. The stock has had a mixed few weeks, with a 2.17% 1 day share price return and 3.70% 7 day share price return contrasting with a 3.55% 30 day share price decline. However, a 28.93% 90 day share price return and 51.07% 1 year...

DiDi Global Inc. reported past fourth-quarter 2025 sales of CNY 58,445 million, narrowing its net loss to CNY 338 million, while full-year 2025 sales reached CNY 226,701 million with net income of CNY 992 million. A subsequent downgrade to Neutral by Macquarie highlighted how DiDi’s heavy spending on expanding food delivery in Brazil is weighing on its international profitability despite improving group-level results. Next, we’ll examine how DiDi’s aggressive Brazil food delivery investment...

Wondering if Kimbell Royalty Partners at around US$14.40 is offering fair value, a bargain, or something in between? This article walks through the key signals that matter for you. The unit price sits near US$14.40, with returns of 19.7% year to date and 14.4% over the past year, while the last 7 days show a 1.5% decline and the past month a 2.3% gain. Recent coverage has focused on Kimbell Royalty Partners as an income oriented oil and gas royalty name. Investors are watching how commodity...

Investors may be wondering whether Arista Networks is attractively priced after such a strong run, or if the market has already incorporated the key positives. The stock trades at US$136.07, with a 1.8% return year to date, a 61.2% return over the last year and a very large 5-year gain of around 7x, even though the past month and week show 3.9% and 1.6% declines respectively. Recent headlines have focused on Arista's role in networking infrastructure for cloud and data center customers, with...

In early March 2026, First Solar reported that policy uncertainty, permitting delays and flat 2026 guidance could leave net sales below analyst expectations, even as it prepares to open a South Carolina finishing line to improve freight efficiency, lower tariff exposure and increase use of local inputs. At the same time, institutional investors and analysts highlighted that First Solar’s differentiated thin-film technology and strong demand for U.S.-made modules are helping the company stand...

Geopolitical conflict in Iran is raising fresh risks for energy markets and Bitcoin miners. Oil traders are watching for crude prices potentially moving above US$100 a barrel, which could feed into higher electricity costs. Bitcoin miners such as NasdaqCM:MARA face direct exposure through power-intensive operations and indirect exposure via crypto and equity market volatility. MARA Holdings, listed as NasdaqCM:MARA, runs energy hungry Bitcoin mining operations that are tightly linked to...

FedEx (FDX) is back in focus after recent trading pressure, with the share price closing at $349.74 and showing a 6.7% decline over the past month, despite a 21.8% gain over the past 3 months. See our latest analysis for FedEx. Over the past year, FedEx has delivered a 44.7% total shareholder return. With a 19.3% year-to-date share price return following a 21.8% three-month gain, momentum has recently cooled. If you are weighing FedEx against other opportunities in a market shaped by...

Wondering whether Exponent at around US$64.50 still makes sense for your portfolio, or if the price is out of line with its underlying worth? The stock has seen a 7.4% decline over the past week, with returns of 6.1% lower over 30 days, 8.1% lower year to date and 18.3% lower over the past year, putting recent price action firmly on readers' radars. These moves come as investors continue to reassess established consulting and professional services businesses, weighing long term demand for...

Earlier this year, Hertz announced it would add the INEOS Grenadier 4X4 in high-spec Fieldmaster trim to its U.S. rental fleet at select airport locations, offering what it describes as the largest pool of Grenadiers available for rent in the country. This move broadens Hertz’s premium offering while giving renters rare access to a rugged, globally marketed off-road vehicle that is still building its presence in the Americas. Next, we’ll examine how expanding access to the premium INEOS...

Earlier in March 2026, Xenon Pharmaceuticals completed a roughly US$650.00 million follow-on equity offering of common shares and pre-funded warrants, shortly after reporting positive Phase 3 X-TOLE2 topline results for azetukalner in highly treatment-resistant focal onset seizures. The X-TOLE2 data showed very large, statistically significant seizure reductions and a safety profile consistent with prior studies, positioning azetukalner as a potential first-in-class KV7 potassium channel...

Recent share performance and business snapshot Kinsale Capital Group (KNSL) has recently attracted attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, year to date, and over the past year. At a last close of US$348.30 and a market value of about US$8.2b, Kinsale continues to operate as a focused U.S. property and casualty insurer, generating US$1,873.987m in revenue and US$503.614m in net income. Recent annual...

SIGA Technologies, Inc. reported past fourth-quarter 2025 results with revenue of US$3.8 million and a net loss of US$5.4 million, while full-year 2025 revenue reached US$94.57 million with net income of US$23.28 million. At the same time, confirmation of a more severe mpox case in New York City has renewed attention on SIGA’s smallpox-related antiviral portfolio despite weaker quarterly earnings. Next, we’ll examine how the severe mpox case and SIGA’s focus on smallpox-related antivirals...

Recent performance snapshot Tyler Technologies (TYL) has seen mixed share-price moves recently, with a 1-day and 7-day decline, a gain over the past month, and weaker performance over the past 3 months, year to date, and past year. See our latest analysis for Tyler Technologies. At a share price of $343.95, Tyler Technologies has seen a strong 30 day share price return of 13.16% but weaker 90 day share price and 1 year total shareholder returns, which points to short term momentum after a...

Raytheon, part of NYSE:RTX, received a US$2.01b contract modification to advance the U.S. Air Force’s advanced extremely high frequency terminal program. Collins Aerospace, another RTX business, has started early testing of hybrid-electric drive systems under the EU’s Clean Aviation SWITCH project. Both developments highlight RTX’s roles in U.S. defense communications and emerging low-emission aviation technologies. For investors watching NYSE:RTX, these updates span two core areas of the...

Edison International (NYSE:EIX) has approved higher executive compensation while facing responsibility for the deadly Eaton wildfire. The company is managing ongoing lawsuits related to the fire, which caused significant loss of life and damage to affected communities. Investors are weighing the pay decisions against legal exposure, reputational risk, and the utility's role in regional power infrastructure. Edison International, the parent of Southern California Edison, is a major regulated...

Jazz Pharmaceuticals (JAZZ) highlighted its oncology pipeline with plans for one oral and six poster presentations at the 2026 AACR meeting, featuring new data on zanidatamab, JZP898, and dordaviprone. See our latest analysis for Jazz Pharmaceuticals. The AACR pipeline update comes as Jazz Pharmaceuticals' share price sits at US$180.45, with a 30 day share price return of 8.5% and a 1 year total shareholder return of 27.01%, suggesting momentum has recently strengthened after a softer...

Earlier this year, Celsius Holdings reported very strong fourth-quarter results, with revenue growth far above analyst expectations, and Bank of America upgraded its rating while management outlined a 17% increase in North American shelf space by 2026 through PepsiCo’s distribution network. This combination of rapid sales expansion and planned shelf-space growth highlights how deeply Celsius is embedding its products within major retail channels. Next, we’ll examine how the planned 17%...

What Figma’s recent trading means for investors Figma (FIG) has drawn investor attention after recent trading left the stock about 33% lower year to date, following a gain over the past month and a loss over the past 3 months. See our latest analysis for Figma. The recent pattern, with a 1 day share price return of 8% decline and a 7 day share price return of 9.3% decline, alongside a 30 day share price return of 12.1% gain, suggests short term momentum is trying to recover within a weak year...

UP Fintech Holding (NasdaqGS:TIGR) has drawn attention after recent trading, with the share price at US$7.05 and returns negative over the past week, month, past 3 months, and year to date. See our latest analysis for UP Fintech Holding. Recent trading has been weak, with the share price at US$7.05 and a 30 day share price return showing a 12.2% decline. However, the 3 year total shareholder return of 134.22% presents a very different longer term picture. If you are comparing UP Fintech...